CA2170285A1 - Utilisation d'esters d'acide 1,4-dihydropyridinedicarboxylique alkyle en n, comme medicaments - Google Patents
Utilisation d'esters d'acide 1,4-dihydropyridinedicarboxylique alkyle en n, comme medicamentsInfo
- Publication number
- CA2170285A1 CA2170285A1 CA002170285A CA2170285A CA2170285A1 CA 2170285 A1 CA2170285 A1 CA 2170285A1 CA 002170285 A CA002170285 A CA 002170285A CA 2170285 A CA2170285 A CA 2170285A CA 2170285 A1 CA2170285 A1 CA 2170285A1
- Authority
- CA
- Canada
- Prior art keywords
- general formula
- carbon atoms
- compounds
- methyl
- atherosclerotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne l'utilisation comme médicaments anti-athérosclérose, d'esters d'acide 1-4-dihydropyridin dicarboxylique N-alkylés partiellement connus de la formule (I), dans laquelle R<1> à R<6> ont la notation mentionnée dans la description. L'invention concerne notamment leur utilisation pour assurer la prophylaxie de la resténose après des angioplasties et des interventions chirurgicales vasculaires.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4328884A DE4328884A1 (de) | 1993-08-27 | 1993-08-27 | Verwendung von N-alkylierten 1,4-Dihydropyridincarbonsäureestern als Arzneimittel |
DEP4328884.7 | 1993-08-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2170285A1 true CA2170285A1 (fr) | 1995-03-02 |
Family
ID=6496196
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002170285A Abandoned CA2170285A1 (fr) | 1993-08-27 | 1994-08-16 | Utilisation d'esters d'acide 1,4-dihydropyridinedicarboxylique alkyle en n, comme medicaments |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0714301A1 (fr) |
JP (1) | JPH09501923A (fr) |
KR (1) | KR960703594A (fr) |
CN (1) | CN1129906A (fr) |
AU (1) | AU7613594A (fr) |
BG (1) | BG100367A (fr) |
CA (1) | CA2170285A1 (fr) |
CZ (1) | CZ43896A3 (fr) |
DE (1) | DE4328884A1 (fr) |
HU (1) | HUT75302A (fr) |
NO (1) | NO960777L (fr) |
PL (1) | PL313116A1 (fr) |
WO (1) | WO1995005823A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19741694C2 (de) * | 1997-09-18 | 2002-10-31 | Schering Ag | Verwendung von Komplexen, deren Ligand ein Bis-Amin-Oxim-Derivat oder ein N¶2¶S¶2¶-Derivat und deren Zentralatom ein Radionuklid ist |
EP1458682B1 (fr) * | 2001-12-20 | 2006-08-30 | Bayer HealthCare AG | Derives de 1,4-dihydro-1,4-diphenylpyridine |
CA2854252C (fr) * | 2011-11-24 | 2016-11-29 | Lipidart Kutato Fejleszto Es Tanacsado Kft. | Derives de 1,4-dihydropyridine ayant une activite modulant hsp |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3222367A1 (de) * | 1982-06-15 | 1983-12-15 | Bayer Ag, 5090 Leverkusen | Verwendung von 1,4-dihydropyridinen in antiarteriosklerotika und deren herstellung |
EP0169009A3 (fr) * | 1984-07-17 | 1988-08-31 | FISONS plc | Dérivés de dihydropyridine et leur préparation, leur formulation et leur utilisation comme produits pharmaceutiques |
DE4011695A1 (de) * | 1990-04-11 | 1991-10-17 | Bayer Ag | Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsaeureestern als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung |
-
1993
- 1993-08-27 DE DE4328884A patent/DE4328884A1/de not_active Withdrawn
-
1994
- 1994-08-16 JP JP7507325A patent/JPH09501923A/ja not_active Ceased
- 1994-08-16 CZ CZ96438A patent/CZ43896A3/cs unknown
- 1994-08-16 KR KR1019960700944A patent/KR960703594A/ko not_active Application Discontinuation
- 1994-08-16 CA CA002170285A patent/CA2170285A1/fr not_active Abandoned
- 1994-08-16 HU HU9600472A patent/HUT75302A/hu unknown
- 1994-08-16 PL PL94313116A patent/PL313116A1/xx unknown
- 1994-08-16 EP EP94926199A patent/EP0714301A1/fr not_active Withdrawn
- 1994-08-16 AU AU76135/94A patent/AU7613594A/en not_active Abandoned
- 1994-08-16 WO PCT/EP1994/002723 patent/WO1995005823A1/fr not_active Application Discontinuation
- 1994-08-16 CN CN94193170A patent/CN1129906A/zh active Pending
-
1996
- 1996-02-19 BG BG100367A patent/BG100367A/xx unknown
- 1996-02-26 NO NO960777A patent/NO960777L/no unknown
Also Published As
Publication number | Publication date |
---|---|
DE4328884A1 (de) | 1995-03-02 |
CN1129906A (zh) | 1996-08-28 |
AU7613594A (en) | 1995-03-21 |
PL313116A1 (en) | 1996-06-10 |
HUT75302A (en) | 1997-05-28 |
JPH09501923A (ja) | 1997-02-25 |
EP0714301A1 (fr) | 1996-06-05 |
WO1995005823A1 (fr) | 1995-03-02 |
HU9600472D0 (en) | 1996-04-29 |
CZ43896A3 (en) | 1996-05-15 |
BG100367A (en) | 1996-07-31 |
NO960777D0 (no) | 1996-02-26 |
KR960703594A (ko) | 1996-08-31 |
NO960777L (no) | 1996-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1205480A (fr) | Dihydropyridine anti-ischemique antihypertenseur, procede de production et composes pharmaceutiques les contenant | |
JP2972377B2 (ja) | カテコール誘導体、その薬学的に許容しうる塩およびエステルならびにそれらを含有する医薬組成物 | |
PL214701B1 (pl) | Pochodna piperydyny, kompozycja farmaceutyczna zawierajaca te pochodna oraz zastosowanie lecznicze tej pochodnej | |
KR19980703023A (ko) | 혈관내막 비후억제제 | |
CZ541388A3 (en) | Derivatives of 1,4-dihydropyridine, process of their preparation and pharmaceutical compositions containing thereof | |
CA2170285A1 (fr) | Utilisation d'esters d'acide 1,4-dihydropyridinedicarboxylique alkyle en n, comme medicaments | |
EP1490339A1 (fr) | Nouveaux derives de chalcone et leurs utilisations | |
RU2339381C2 (ru) | Ингибитор гиперплазии интимы сосудов | |
WO2012149093A1 (fr) | Dérivés de 2-guanidino-4-oxo-imidazoline en tant qu'agents antipaludiques, synthèse et procédés d'utilisation de ceux-ci | |
DD228547A5 (de) | Verfahren zur herstellung von neuen amid-verbindungen | |
CA2228385A1 (fr) | Composes analogues a la thalidomide de la classe comprenant les piperidine-2,6-diones | |
EP0718289A1 (fr) | Nouveaux dérivés d'acide parabanique comme inhibiteurs d'aldose réductase | |
EP0718290A1 (fr) | Dérivés carboxyalcoyle hétérocycliques | |
JP2838282B2 (ja) | 血管攣縮治療剤 | |
EP0395526B1 (fr) | Nouveaux dérivés benzothiazolinoniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent | |
JPH05262646A (ja) | 肝障害抑制剤 | |
JPH0680041B2 (ja) | 2−ピリジル酢酸誘導体、その製法およびそれを含む医薬 | |
JPS5976083A (ja) | ジヒドロピリジン類 | |
CH641775A5 (fr) | N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, son procede de preparation et composition le renferment. | |
JP3175278B2 (ja) | 尿酸排泄促進剤 | |
HU185802B (en) | Process for producing 1,2,4-triazine derivatives | |
CS240982B2 (en) | Production method of pyrrolidine derivatives | |
JPH111479A (ja) | アミド結合を有するイソオキサゾール誘導体、並びにこれらを含有するキマーゼ阻害剤及びアンジオテンシンii産生抑制剤 | |
FR2551756A1 (fr) | Derives de 4,7-dihydropyrazolo (3,4-b)pyridine et composition pharmaceutique a action anti-hypertensive et de vasodilatation coronaire les renfermant | |
WO1992014730A1 (fr) | Derive de thiazolidine-2,4-dione, sel dudit derive et leur production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |